Teclistamab: Mechanism of action, clinical, and translational science

• Main Authors: Yue Guo (Author), Natalia A. Quijano Cardé (Author), Lijuan Kang (Author), Raluca Verona (Author), Arnob Banerjee (Author), Rachel Kobos (Author), Katherine Chastain (Author), Clarissa Uhlar (Author), Kodandaram Pillarisetti (Author), Margaret Doyle (Author), Jennifer Smit (Author), Nahor Haddish‐Berhane (Author), Daniele Ouellet (Author)
• Format: Book
• Published: Wiley, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Multiple myeloma (MM) remains incurable despite improvements in treatment options. B‐cell maturation antigen (BCMA) is predominantly expressed in B‐lineage cells and represents a promising new target for MM. Teclistamab (TECVAYLITM) is the first T‐cell redirecting bispecific antibody approv...